Document is current

Correction: Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib

Crossref DOI link: https://doi.org/10.1136/jitc-2019-000317corr1

Published Online: 2020-04-09

Published Print: 2020-04

Update policy: https://doi.org/10.1136/crossmarkpolicy